MedPath

Effect of Landiolol as an adjunct to Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarctio

Phase 3
Conditions
Acute myocardial infarction
Registration Number
JPRN-UMIN000001872
Lead Sponsor
Cardiovascular Division, University of Tsukuba, Graduate School of Comprehensive Human Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
88
Inclusion Criteria

Not provided

Exclusion Criteria

1) history of OMI or CABG 2) LMT 3) suspected aortic dissection 4) systolic blood pressure of less than 90 mmHg or bradycardia of less than 60 beats/min 5) more than II-AV block or 2 bundle block 6) severe liver and/or kidney dysfunction 7) bronchial athma 8) history of beta-blocker or amiodarone 9) history of side effects or contraindication of beta-blocker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath